ClinicalTrials.Veeva

Menu

Body Water Content in Cyanotic Congenital Heart Disease

N

National Center for Research Resources (NCRR)

Status

Completed

Conditions

Heart Defects, Congenital

Study type

Observational

Funder types

NIH

Identifiers

NCT00000107
M01RR000109 (U.S. NIH Grant/Contract)
NCRR-M01RR00109-0737

Details and patient eligibility

About

Adults with cyanotic congenital heart disease have elevated levels of plasma proatrial natruretic peptide (proANP) which most likely results in chronic dehydration, leading to reduced oxygen transport to tissues and shortness of breath with activity. The purpose of this study is to characterize adults with cyanotic congenital heart defects with respect to their body composition (water and fat-free mass) and resting metabolic rates. The study consists of several measures of how much body water, fat and lean tissue a subject has, and measures the number of calories the subject's body uses at rest. Adult subjects with cyanotic congenital heart disease will be recruited along with healthy noncyanotic control subjects matched for age, gender, and body weight.

Sex

All

Ages

17 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Resting blood pressure below 140/90

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems